ArticleCancer medicine2025
A Case Control Study Examining the Patterns and Predictors of Referral to Cancer Rehabilitation at Canada's Largest Comprehensive Cancer Centre.
Article in Cancer medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Patient-initiated rehabilitation after radiotherapy: gender and sociodemographic differences despite standardized support - a German retrospective single-center study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
- A Case Control Study Examining the Patterns and Predictors of Referral to Cancer Rehabilitation at Canada's Largest Comprehensive Cancer Centre.Cancer medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundCancer rehabilitation has become increasingly relevant as the number of cancer survivors grows, coupled with the high-documented rates of adverse effects and related disability. Cancer rehabilitation can reduce functional limitations among cancer survivors and enhance their well-being. However, only a small proportion of individuals are referred to rehabilitation services. To identify and address disparities and foster access, it is essential to develop a better understanding of the factors that drive referral to cancer rehabilitation services.
methodsThe purpose of this study was to: (1) describe the sociodemographic and clinical characteristics and symptom burden of patients who were referred to the Princess Margaret Cancer Rehabilitation and Survivorship (CRS) Program between 2017 and 2019 and (2) Compare these variables between patients who were referred to CRS (n = 2783) and matched cases who were not referred over this period (n = 18,434). A retrospective secondary analysis of data extracted from the Princess Margaret (PM) Cancer Registry, electronic patient records, and patient-reported outcome data (PROMs) (including ESAS-r and ECOG status) was performed. Summary statistics were used to describe the patients referred to the CRS program. Multivariable logistic regression modelling was used to identify factors associated with likelihood of referral.
resultsMost referred patients were female (74%), English speakers (93%) and half lived within 15 km of the referred hospital. The most common reasons for referral were musculoskeletal impairment (26%) and lymphedema (25.4%). Many patients (45%) had multiple reasons for referral. Several key predictors of referral were identified including closer distance to hospital, lower age (< 65 years), cancer site, and completion of PROMs. For those who completed PROMs, patient reported function status and pain scores were related to referral.
conclusionThe findings can be helpful in optimizing the referral processes and addressing disparities regarding access to cancer rehabilitation. Solutions are likely multifaceted including health care provider and patient education and systemic changes to address barriers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.